v3 Template
K

Kimia Therapeutics Inc.

Biotechnology / Drug Discovery Berkeley, Calif. ~135 employees
Founded
--
Employees (Est.)
~135
9 leaders known
Total Funding
$55.0M
Funding Rounds
1
Last Funding
2023-12-19

About Kimia Therapeutics Inc.

Kimia Therapeutics is focused on generating a chemical atlas for treating human disease through innovative drug discovery. Their mission is to transform the landscape of drug discovery by leveraging ATLAS technology, which combines active learning, automated synthesis, and screening to uncover therapeutic targets and identify novel drug molecules.

Products & Services

ATLAS Technology:A revolutionary platform that merges active learning with automated synthesis and screening, using machine learning to accelerate the discovery of novel drugs and create a chemical atlas of druggable space.
Generative Chemistry:Based on iterations of chemical design, high-throughput synthesis, chemical biology, and machine learning to map relationships between chemical structure and protein function at single-atom resolution.
Target-directed Precision Chemistry:Enables access to billions of target-directed compounds on demand, generating vast chemical and biological data for drug design and lead optimization using machine learning.

Specialties

Machine Learning in Drug Design Generative Chemistry Precision Chemistry Automated Synthesis and Screening Chemical Biology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A
A: 55000000
MR: -
FA: 55 million
FAN: 55000000
D: 2023-12-19
FD: 2023-12-19
4 investors
Series A Latest
2023-12-19
$55.0M
4 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Stig K. Hansen

Co-founder & Chief Executive Officer, President

J

Jack Sadowsky

Co-founder & Vice President, Discovery Chemistry

R

Ray Fucini

Co-founder & Sr Director, Discovery Platform Technology

M

Melissa Paoloni

Senior Vice President of Operations

T

Thilo Heckrodt

Vice President, Medicinal Chemistry

J

JW Feng

Head of Computational Science

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Kimia Therapeutics Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Drug Discovery
Company Size
~135 employees (est.)
Locations
Berkeley, Calif.

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro